AURKA and prostate carcinoma: Moreover, the enhancement of miR-199a methylation results in the down-regulation of miR-199a-3p, and miR-199a-3p inhibits aurora kinase A and attenuates xenograft tumor growth in prostate cancer (Qu et al., 2014).